Viewing StudyNCT03529877

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 12:46 PM
Study NCT ID: NCT03529877
Status: COMPLETED
Last Update Posted: 2022-10-07
First Post: 2018-04-24
Brief Title: Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa
Sponsor: RHEACELL GmbH Co KG
Organization: RHEACELL GmbH Co KG
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Recessive Dystrophic Epidermolysis Bullosa
Keywords:
Name View
Allogeneic View
Epidermolysis Bullosa View
Epidermolysis Bullosa Dystrophica View
Skin Abnormalities View
Congenital Abnormalities View
Skin Diseases Genetic View
Somatic Cell Therapy View
Mesenchymal Stem Cells View
ABCB5 View